Adverse event development in clinical oncology trials

Lancet Oncol. 2016 Jul;17(7):e263. doi: 10.1016/S1470-2045(16)30197-8.

Authors

Iris Walraven¹, Neil Aaronson², Jan-Jakob Sonke¹, Marcel Verheij¹, José Belderbos³

Affiliations

¹ Department of Radiation Oncology, Netherlands Cancer Institute, Amsterdam 1006 BE, Netherlands.
² Department of Epidemiology and Biostatistics, Netherlands Cancer Institute, Amsterdam 1006 BE, Netherlands.
³ Department of Radiation Oncology, Netherlands Cancer Institute, Amsterdam 1006 BE, Netherlands. Electronic address: j.belderbos@nki.nl.

PMID: 27396639
DOI: 10.1016/S1470-2045(16)30197-8

No abstract available

Publication types

Letter
Comment

MeSH terms

Clinical Trials as Topic
Humans
Medical Oncology*
Neoplasms*